Immunomedics

Immunomedics
Company typePublic
Nasdaq: IMMU
IndustryBiotechnology
FoundedJuly 1982 (1982-07)
FounderDavid M. Goldenberg
DefunctOctober 23, 2020 (2020-10-23)
HeadquartersMorris Plains, New Jersey
ParentGilead Sciences
Websitewww.immunomedics.com 

Immunomedics was a biotechnology company focused on the development of antibody-drug conjugates for the treatment of cancer. In 2020, the company was acquired by Gilead Sciences.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.